SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/27/2019
Entire Document
 

 

(ii)       authorizing the Debtors to use the proceeds of the DIP Facility as provided in the DIP Loan Documents and solely in accordance with the Approved Budget, including use of the proceeds of the DIP Facility and Cash Collateral (as defined below), to refinance and discharge the Prepetition Revolving Debt outstanding as of the entry of this Interim Order in full, including postpetition interest and fees through the date of repayment, which refinancing and discharge shall be indefeasible upon the occurrence of the Revolver Discharge (as defined below);

 

(iii)       authorizing the DIP Loan Parties to execute and enter into the DIP Loan Documents and to perform such other and further acts as may be required in connection with the DIP Loan Documents;

 

(iv)       authorizing the Debtors to use Cash Collateral and all other Prepetition Collateral on the terms and conditions set forth in this Interim Order, the DIP Loan Documents, and the Intercreditor Agreement;

 

(v)       authorizing the DIP Loan Parties to grant adequate protection to the Prepetition Secured Parties and Prepetition Agents under and in connection with the Prepetition Financing Documents or the TSA, as applicable, and this Interim Order, including without limitation, granting the Adequate Protection Liens (as defined below) in accordance with the relative priorities set forth herein;

 

(vi)       authorizing the DIP Loan Parties to grant security interests, liens and superpriority claims (including a superpriority administrative claim pursuant to section 364(c)(1) of the Bankruptcy Code, liens pursuant to sections 364(c)(2) and 364(c)(3) of the Bankruptcy Code and priming liens pursuant to section 364(d) of the Bankruptcy Code) in favor of the DIP

 

3